Goldman Sachs adds Amylin Pharmaceuticals (AMLN) to its Conviction Buy List
Tweet Send to a Friend
Goldman Sachs adds Amylin Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
